Robert B. Bazemore - 16 May 2022 Form 4/A - Amendment Insider Report for Nuvation Bio Inc. (NUVB)

Role: Director
Signature: Robert B. Bazemore, Jr., by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol: NUVB
Transactions as of: 16 May 2022
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 28 Jun 2022, 19:07:44 UTC
Date Of Original Report: 18 May 2022
Previous filing: 02 Nov 2021
Next filing: 17 Jun 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NUVB	Stock Option (Right to Buy)	Award	$0	+140,713		$0.000000	140,713	16 May 2022	Class A Common Stock	140,713	$4.05	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 16, 2023); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.

Remarks:

This amendment is being filed solely to correct the number of shares covered by the stock option granted on May 16, 2022, which was erroneously reported in the original Form 4 due to an administrative error.